Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisabetta Puliga
Observed name:
E. Puliga
Institution:
Candiolo Cancer Institute
Observed institutions:
University of Pittsburgh,
University of Cagliari,
University of Pittsburgh Medical Center,
Candiolo Cancer Institute,
University of Turin
ORCID:
0000-0002-1049-9728
Observed ORCID:
0000-0002-1049-9728
OpenAlex ID:
A5044872348
Works
65
Awards
2
Microsatellite instability in Gastric Cancer: Between lights and shadows
2021
·
Elisabetta Puliga
, Simona Corso
, et al.
·
Cancer Treatment Reviews
·
262
PDF
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming
2020
·
Marta Anna Kowalik
, Elisabetta Puliga
, et al.
·
Journal of Hepatology
·
71
PDF
Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration
2016
·
Tamara Feliciano Alvarado
, Elisabetta Puliga
, et al.
·
Gene Expression
·
50
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2023
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
·
Cancer Research
·
26
PDF
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin–Driven Hepatocellular Cancer
2017
·
Elisabetta Puliga
, Qian Min
, et al.
·
American Journal Of Pathology
·
26
PDF
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
2020
·
Claudia Orrù
, Andrea Perra
, et al.
·
Cancers
·
19
PDF
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes
2023
·
Marta A. Kowalik
, Keiko Taguchi
, et al.
·
Hepatology
·
13
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models
2024
·
Elisabetta Puliga
, Chiara De Bellis
, et al.
·
Gastric Cancer
·
8
PDF
The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation
2017
·
Marta Szydlowska
, Monica Pibiri
, et al.
·
Gene Expression
·
8
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
2021
·
Sandra Mattu
, Patrizia Zavattari
, et al.
·
Cellular and Molecular Gastroenterology and Hepatology
·
5
PDF
The origin of the Sardinian Blue, Pseudophilotes barbagiae (Lycaenidae): Out-of-Europe or Out-of-Africa?
2015
·
Valentina Todisco
, Konrad Fiedler
, et al.
·
DIGITAL.CSIC (Spanish National Research Council (CSIC))
·
4
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma
2022
·
Marina Serra
, Rajesh Pal
, et al.
·
Frontiers in Oncology
·
1
Abstract 3919: The emerging role of claudin 18.2 as a potential driver in gastric cancer progression.
2026
·
Lisa Negro
, Elisabetta Puliga
, et al.
·
Cancer Research
Figure S1 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Supplementary Table S2 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Supplementary Methods from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Figure S8 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
Supplementary Table S3 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Figure S3 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
Figure S2 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
Figure S4 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Figure S7 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Figure S6 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Figure S5 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Supplementary Table S1 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
2025
·
Annalisa Petrelli
, Sabrina Rizzolio
, et al.
PDF
Show more works
View as search
Works count:
65
Citation count:
493
H-index:
8
I10-index:
7
Year
Topic
Type